Literature DB >> 11390621

Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis.

T Seo1, J Park, D Lee, S G Hwang, J Choe.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is related to the development of Kaposi's sarcoma. Open reading frame K9 of KSHV encodes viral interferon regulatory factor 1 (vIRF1), which functions as a repressor of interferon- and IRF1-mediated signal transduction. In addition, vIRF1 acts as an oncogene to induce cellular transformation. Here we show that vIRF1 directly associates with the tumor suppressor p53 and represses its functions. The vIRF1 interaction domains of p53 are the DNA binding domain (amino acids [aa] 100 to 300) and the tetramerization domain (aa 300 to 393). p53 interacts with the central region (aa 152 to 360) of vIRF1. vIRF1 suppresses p53-dependent transcription and deregulates its apoptotic activity. These results suggest that vIRF1 may regulate cellular function by inhibiting p53.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390621      PMCID: PMC114335          DOI: 10.1128/JVI.75.13.6193-6198.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  p53 inhibition by the LANA protein of KSHV protects against cell death.

Authors:  J Friborg; W Kong; M O Hottiger; G J Nabel
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

2.  Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor.

Authors:  M Li; B Damania; X Alvarez; V Ogryzko; K Ozato; J U Jung
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

3.  The K-bZIP protein from Kaposi's sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity.

Authors:  J Park; T Seo; S Hwang; D Lee; Y Gwack; J Choe
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.

Authors:  C Parravicini; B Chandran; M Corbellino; E Berti; M Paulli; P S Moore; Y Chang
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

5.  cAMP response element-binding protein-binding protein binds to human papillomavirus E2 protein and activates E2-dependent transcription.

Authors:  D Lee; B Lee; J Kim; D W Kim; J Choe
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

6.  Oligomerization of oncoprotein p53.

Authors:  S Kraiss; A Quaiser; M Oren; M Montenarh
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

7.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

8.  Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) binds to, and inhibits transactivation of, CREB-binding protein.

Authors:  T Seo; D Lee; B Lee; J H Chung; J Choe
Journal:  Biochem Biophys Res Commun       Date:  2000-04-02       Impact factor: 3.575

9.  Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53.

Authors:  C Rivas; A E Thlick; C Parravicini; P S Moore; Y Chang
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

10.  Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease.

Authors:  H Katano; Y Sato; T Kurata; S Mori; T Sata
Journal:  Virology       Date:  2000-04-10       Impact factor: 3.616

View more
  57 in total

Review 1.  Kaposi's sarcoma and its associated herpesvirus.

Authors:  Enrique A Mesri; Ethel Cesarman; Chris Boshoff
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

Review 2.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

Review 3.  The IRF family, revisited.

Authors:  A Paun; P M Pitha
Journal:  Biochimie       Date:  2007-02-20       Impact factor: 4.079

4.  Identification of the DNA sequence interacting with Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 1.

Authors:  Junsoo Park; Myung-Shin Lee; Seung-Min Yoo; Kwi Wan Jeong; Daeyoup Lee; Joonho Choe; Taegun Seo
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

Review 5.  Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication.

Authors:  Emily Cousins; John Nicholas
Journal:  Recent Results Cancer Res       Date:  2014

6.  Inhibition of primary effusion lymphoma engraftment in SCID mice by morpholino oligomers against early lytic genes of Kaposi's sarcoma-associated herpesvirus.

Authors:  Yan-Jin Zhang; Deendayal Patel; Yuchen Nan; Sumin Fan
Journal:  Antivir Ther       Date:  2011

Review 7.  Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.

Authors:  Qiliang Cai; Suhbash C Verma; Jie Lu; Erle S Robertson
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

8.  Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death.

Authors:  Taegun Seo; Daeyoup Lee; Young Sam Shim; Jon E Angell; Natesa V Chidambaram; Dhananjaya V Kalvakolanu; Joonho Choe
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Mutational analysis of TP53, PTEN, PIK3CA and CTNNB1/beta-catenin genes in human herpesvirus 8-associated primary effusion lymphoma.

Authors:  Emmanuelle Boulanger; Agnès Marchio; Saw-See Hong; Pascal Pineau
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

10.  Bim nuclear translocation and inactivation by viral interferon regulatory factor.

Authors:  Young Bong Choi; John Nicholas
Journal:  PLoS Pathog       Date:  2010-08-05       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.